Sample Name
Sample Code
Sample Name
Sample Code
Sample Name
Sample Code
4
BIDU-SW
09888
5
JD HEALTH
06618
| (Q9)Sep 30, 2025 | (Q6)Jun 30, 2025 | (Q1)Mar 31, 2025 | (FY)Dec 31, 2024 | (Q9)Sep 30, 2024 | (Q6)Jun 30, 2024 | (Q1)Mar 31, 2024 | (FY)Dec 31, 2023 | (Q9)Sep 30, 2023 | (Q6)Jun 30, 2023 | |
|---|---|---|---|---|---|---|---|---|---|---|
| Operating Cash Flow | ||||||||||
| Cash received from interests, fees and commissions | 31.60%3.01B | 18.16%1.75B | 22.65%892.48M | 3.03%3.4B | -7.01%2.29B | -11.11%1.48B | 22.95%727.68M | 4.66%3.3B | 7.98%2.46B | 20.60%1.66B |
| Net increase in repurchase business capital | --7.18B | --17.11B | --9.97B | ---- | ---- | ---- | ---- | ---- | ---- | ---- |
| Net increase in funds disbursed | 775.00%1.75B | --2.08B | --650M | --540M | --200M | ---- | ---- | ---- | ---- | ---- |
| Net cash received from trading securities | 13.80%4.25B | -64.62%569.29M | ---- | --5.51B | --3.73B | 840.47%1.61B | 112.06%1.22B | ---- | ---- | -86.19%171.11M |
| Cash received relating to other operating activities | -14.01%6.3B | -31.12%3.13B | -31.25%3.32B | 22.92%10.33B | -35.92%7.33B | -37.26%4.54B | 75.05%4.82B | 140.68%8.4B | 335.86%11.44B | 262.29%7.24B |
| Special items of operating cash inflws | ---- | ---- | ---- | 8,826.17%14.78B | ---- | ---- | ---- | --165.63M | ---- | ---- |
| Cash inflows from operating activities | -4.77%22.54B | 91.04%25.07B | 51.05%14.83B | 143.70%36.09B | 50.81%23.67B | 9.66%13.12B | 64.39%9.82B | 8.48%14.81B | 23.60%15.69B | 7.21%11.97B |
| Staff behalf paid | 2.05%1.33B | 5.45%1.02B | 1.44%276.41M | 2.56%1.68B | -0.17%1.3B | -6.19%964.99M | 3.71%272.5M | 3.72%1.64B | 2.59%1.31B | 4.49%1.03B |
| All taxes paid | 41.03%538.29M | 66.14%355.14M | 160.83%269.01M | -31.92%449.47M | -38.38%381.68M | -52.69%213.76M | -32.50%103.14M | 19.66%660.2M | 23.56%619.44M | 35.06%451.85M |
| Cash paid for fees and commissions | 0.86%724.67M | -2.75%481.09M | -9.26%233.78M | -12.34%756.51M | -0.35%718.47M | 1.03%494.69M | 5.67%257.65M | 8.15%863.05M | 15.55%721.03M | 22.28%489.63M |
| Net increase in financial assets held for trading purposes | --5.44B | --11.38B | --6.34B | ---- | ---- | ---- | ---- | ---- | ---- | -84.11%1.25B |
| Net increase in resale business funds (operating) | ---- | --1.33B | 20.08%3.46B | ---- | ---- | ---- | --2.88B | ---- | -98.93%14.56M | ---- |
| Cash paid relating to other operating activities | 72.01%9.94B | 224.06%11.44B | 147.43%3.81B | 10.07%8.02B | 16.01%5.78B | 1.87%3.53B | -16.09%1.54B | 79.55%7.29B | 21.69%4.98B | 36.17%3.46B |
| Cash outflows from operating activities | 22.23%19.5B | 169.17%26B | 95.18%14.93B | 64.87%24.01B | 4.38%15.96B | -19.46%9.66B | 17.14%7.65B | -20.86%14.56B | -9.38%15.29B | -19.55%11.99B |
| Net cash flows from operating activities | -60.66%3.03B | -126.83%-929.51M | -104.62%-100.23M | 4,721.79%12.09B | 1,805.63%7.71B | 13,252.63%3.46B | 488.53%2.17B | 105.28%250.71M | 109.69%404.48M | 99.30%-26.34M |
| Investing cash flow | ||||||||||
| Cash received from disposal of investments | -16.69%201.14M | 80.15%166.29M | 22.12%42.05M | ---- | -15.10%241.42M | -58.97%92.31M | -21.31%34.44M | ---- | -2.39%284.36M | 27.11%224.99M |
| Cash received from returns on investments | ---- | ---- | ---- | ---- | ---- | ---- | ---- | -93.12%322.05K | -93.06%322.05K | -98.29%322.05K |
| Net cash received from disposal of fix assets、 intangible assets 、other long-term asset | 101.86%103.79K | 1,234.05%72.97K | 1,771.66%22.84K | -56.25%383.39K | -57.39%51.41K | -96.29%5.47K | -98.65%1.22K | 157.96%876.4K | 21.56%120.66K | 136.21%147.53K |
| Cash received relating to other investing activities | ---- | ---- | ---- | ---- | ---- | ---- | ---- | 3.74%82.8M | ---- | ---- |
| Cash inflows from investing activities | -16.66%201.24M | 80.22%166.37M | 22.18%42.08M | -99.54%383.39K | -15.21%241.47M | -59.06%92.32M | -22.04%34.44M | -9.92%84M | -3.80%284.8M | 15.11%225.46M |
| Cash paid to acquire fixed assets intangible assets and other long-term assets | -21.00%83.18M | -7.02%72.27M | -26.05%38.61M | -16.98%191.95M | -9.92%105.29M | 13.48%77.73M | 195.43%52.22M | 16.48%231.21M | 63.81%116.88M | 35.46%68.5M |
| Cash paid to acquire investments | 49.96%264.41M | 27.51%157.74M | -16.45%52.08M | ---- | -33.56%176.32M | -31.86%123.71M | -0.75%62.34M | ---- | -23.73%265.37M | -23.56%181.55M |
| Net cash paid to acquire subsidiaries and other business units | --382.13M | ---- | ---- | --3.44B | ---- | ---- | ---- | ---- | ---- | ---- |
| Cash outflows from investing activities | 159.13%729.72M | 14.18%230.01M | -20.83%90.7M | 1,471.99%3.63B | -26.33%281.61M | -19.44%201.44M | 42.34%114.55M | 16.48%231.21M | -8.84%382.25M | -13.20%250.04M |
| Net cash flows from investing activities | -1,216.79%-528.48M | 41.68%-63.64M | 39.31%-48.62M | -2,368.72%-3.63B | 58.81%-40.13M | -343.98%-109.12M | -120.68%-80.12M | -39.87%-147.21M | 20.93%-97.45M | 73.34%-24.58M |
| Financing cash flow | ||||||||||
| Cash from bonds issue | -11.78%13.85B | -16.67%10.25B | -46.55%3.1B | -25.54%17.5B | -23.34%15.7B | 9.28%12.3B | 9.02%5.8B | -29.01%23.5B | -17.01%20.48B | -36.25%11.26B |
| Cash from borrowing | 2,135.17%223.52M | --104.15M | --20M | -62.50%15M | -33.33%10M | ---- | ---- | --40M | --15M | ---- |
| Cash received relating to other financing activities | ---- | ---- | ---- | --40.35M | ---- | ---- | ---- | ---- | ---- | ---- |
| Cash inflows from financing activities | -10.42%14.07B | -15.82%10.35B | -46.21%3.12B | -25.44%17.56B | -23.35%15.71B | 9.28%12.3B | 9.02%5.8B | -28.91%23.54B | -16.98%20.49B | -36.29%11.26B |
| Borrowing repayment | -6.69%14.03B | -13.45%10.85B | -1.88%5.61B | -29.79%17.14B | -29.72%15.03B | 3.07%12.53B | 25.93%5.72B | -12.41%24.41B | 15.56%21.39B | 4.43%12.16B |
| Dividend interest payment | -0.25%918.64M | -6.86%783.06M | 12.54%276.49M | 45.28%1.11B | 24.67%920.9M | 35.12%840.74M | 46.51%245.68M | -18.33%766.13M | -13.26%738.64M | -6.04%622.22M |
| Cash payments relating to other financing activities | 57.65%137.52M | -52.20%76M | 430.53%62.64M | -15.51%164.51M | -27.32%87.23M | 284.74%158.98M | -38.38%11.81M | 28.20%194.71M | 3.93%120.02M | -12.67%41.32M |
| Cash outflows from financing activities | -5.97%15.08B | -13.50%11.71B | -0.44%5.95B | -27.41%18.42B | -27.90%16.04B | 5.53%13.53B | 26.40%5.98B | -12.38%25.38B | 14.23%22.25B | 3.80%12.82B |
| Net cash flows from financing activities | -205.22%-1.01B | -9.67%-1.35B | -1,515.40%-2.83B | 52.78%-864.83M | 81.13%-330.78M | 21.38%-1.23B | -129.55%-175.14M | -144.08%-1.83B | -133.65%-1.75B | -129.50%-1.57B |
| Net cash flow | ||||||||||
| Exchange rate change effecting cash and cash equivalents | -34.37%-724.99K | -201.70%-308.04K | -226.15%-90.77K | 37.08%821.53K | -144.58%-539.54K | -79.24%302.9K | 113.49%71.96K | -77.34%599.31K | -63.68%1.21M | -2.88%1.46M |
| Net increase in cash and cash equivalents | -79.65%1.49B | -210.47%-2.35B | -255.66%-2.98B | 539.40%7.59B | 607.77%7.34B | 231.28%2.12B | 88,824.41%1.91B | -149.38%-1.73B | -257.88%-1.44B | -209.49%-1.62B |
| Add:Begin period cash and cash equivalents | 46.84%23.8B | 46.84%23.8B | 46.84%23.8B | -9.63%16.2B | -9.63%16.2B | -9.63%16.2B | -9.63%16.2B | -3.72%17.93B | -3.72%17.93B | -3.72%17.93B |
| End period cash equivalent | 7.42%25.29B | 17.04%21.45B | 14.90%20.82B | 46.84%23.8B | 42.78%23.54B | 12.33%18.33B | 1.05%18.12B | -9.63%16.2B | -15.62%16.49B | -18.84%16.32B |
| Currency Unit | CNY | CNY | CNY | CNY | CNY | CNY | CNY | CNY | CNY | CNY |
| Accounting Standards | CAS (2007) | CAS (2007) | CAS (2007) | CAS (2007) | CAS (2007) | CAS (2007) | CAS (2007) | CAS (2007) | CAS (2007) | CAS (2007) |
| Audit Opinions | -- | -- | -- | Unqualified opinion | -- | -- | -- | Unqualified opinion | -- | -- |
| Auditor | -- | -- | -- | Zhitong Certified Public Accountants (Special General Partnership) | -- | -- | -- | Zhitong Certified Public Accountants (Special General Partnership) | -- | -- |
FY: Financial Year. Refers to the 10-K file disclosed by the listed company to the SEC.
Q: Quarter. Refers to the 10-Q file disclosed by the listed company to the SEC. Q1, Q2, Q3, and Q4 are quarterly reports each with a span of 3 months; Q6 and Q9 are cumulative reports, with Q6 including 6 months and Q9 9 months.